Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma

  1. Martin, T.G.
  2. Mateos, M.V.
  3. Nooka, A.
  4. Banerjee, A.
  5. Kobos, R.
  6. Pei, L.
  7. Qi, M.
  8. Verona, R.
  9. Doyle, M.
  10. Smit, J.
  11. Sun, W.
  12. Trancucci, D.
  13. Uhlar, C.
  14. van de Donk, N.W.C.J.
  15. Rodriguez, C.
Aldizkaria:
Cancer

ISSN: 1097-0142,  0008-543X

Argitalpen urtea: 2023

Alea: 129

Zenbakia: 13

Orrialdeak: 2035-2046

Mota: Artikulua

DOI: 10.1002/CNCR.34756 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus